PBS NewsHour

00:00

Jul 30, 2020 The antibiotics industry has suffered an alarming collapse that has become even more troubling as secondary bacterial infections threaten patients suffering from COVID-19. Why has production of these vital medicines stagnated, and what can be done to address the problem? Economics correspondent Paul Soman reports on why lifesaving drugs don't necessarily translate to lucrative businesses. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

You're listening to
PBS NewsHour
on demand via

Personalized news and talk radio for your commute, workout and on-the-go.